2017
DOI: 10.37469/0507-3758-2017-63-3-440-444
|View full text |Cite
|
Sign up to set email alerts
|

Rebiopsy in Patients With Advanced Non-Small Cell Lung Cancer as the Basis of Individualized Treatment

Abstract: We have conducted a pilot study of repeated tumor biopsy followed by molecular testing in order to facilitate treatment correction in patients with advanced non-small cell lung cancer progressing on their current therapy. Repeated tumor biopsy was showed to be feasible, well tolerated and highly informative. Use of molecular-matched therapy was associated with significant increase in overall survival in this difficult-to-treat group of cancer patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 8 publications
(10 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?